Cracking Cancer 2.0 - Industry/MIT Moment

Karl Koster
Executive Director
MIT Corporate Relations

Cracking Cancer 2.0 - Introductory Remarks
Trond Undheim, PhD, Anne Deconinck, PhD

Paula Hammond, PhD
David H. Koch Professor in Engineering
Department Head, MIT Chemical Engineering
Koch Institute of Integrative Cancer Research Member

Startup lightning talks for Travera, Honeycomb, PanTher Therapeutics, Torque, Elektrofi;, Sextant, Leuko Labs, and Asimov.

Panel discussion moderated by Trond Undheim, Program Director, MIT Startup Exchange. Panelists include: Paula Hammond, PhD, David H. Koch Professor in Engineering, Department Head, Chemical Engineering, MIT, ; Laura Indolfi, PhD, CEO of PanTher Therapeutics; and Peter Sandor, VP, Head of Oncology Marketing Strategy, Astellas.